Cargando…

Response of prostate cancer to addition of dutasteride after progression on abiraterone

Detalles Bibliográficos
Autores principales: Lian, Jian-Po, Gao, Yuan-Yuan, Tang, Jing-Jie, Chen, Xi, Liu, Ying, Wu, Deng-Long, Li, Zhen-Fei, Huang, Sheng-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991817/
https://www.ncbi.nlm.nih.gov/pubmed/32896838
http://dx.doi.org/10.4103/aja.aja_45_20
_version_ 1783669247951503360
author Lian, Jian-Po
Gao, Yuan-Yuan
Tang, Jing-Jie
Chen, Xi
Liu, Ying
Wu, Deng-Long
Li, Zhen-Fei
Huang, Sheng-Song
author_facet Lian, Jian-Po
Gao, Yuan-Yuan
Tang, Jing-Jie
Chen, Xi
Liu, Ying
Wu, Deng-Long
Li, Zhen-Fei
Huang, Sheng-Song
author_sort Lian, Jian-Po
collection PubMed
description
format Online
Article
Text
id pubmed-7991817
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-79918172021-03-26 Response of prostate cancer to addition of dutasteride after progression on abiraterone Lian, Jian-Po Gao, Yuan-Yuan Tang, Jing-Jie Chen, Xi Liu, Ying Wu, Deng-Long Li, Zhen-Fei Huang, Sheng-Song Asian J Androl Letter to the Editor Wolters Kluwer - Medknow 2020-09-08 /pmc/articles/PMC7991817/ /pubmed/32896838 http://dx.doi.org/10.4103/aja.aja_45_20 Text en Copyright: ©The Author(s)(2020) http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letter to the Editor
Lian, Jian-Po
Gao, Yuan-Yuan
Tang, Jing-Jie
Chen, Xi
Liu, Ying
Wu, Deng-Long
Li, Zhen-Fei
Huang, Sheng-Song
Response of prostate cancer to addition of dutasteride after progression on abiraterone
title Response of prostate cancer to addition of dutasteride after progression on abiraterone
title_full Response of prostate cancer to addition of dutasteride after progression on abiraterone
title_fullStr Response of prostate cancer to addition of dutasteride after progression on abiraterone
title_full_unstemmed Response of prostate cancer to addition of dutasteride after progression on abiraterone
title_short Response of prostate cancer to addition of dutasteride after progression on abiraterone
title_sort response of prostate cancer to addition of dutasteride after progression on abiraterone
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991817/
https://www.ncbi.nlm.nih.gov/pubmed/32896838
http://dx.doi.org/10.4103/aja.aja_45_20
work_keys_str_mv AT lianjianpo responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT gaoyuanyuan responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT tangjingjie responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT chenxi responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT liuying responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT wudenglong responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT lizhenfei responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone
AT huangshengsong responseofprostatecancertoadditionofdutasterideafterprogressiononabiraterone